DaVita healthCare Partners Inc Stock News

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and RDNT are well-poised

U.S. Steel (NYSE: X ) announced on Aug. 13 that it was undertaking a strategic review to maximize shareholder value. Once the country's largest steelmaker, it was removed as a constituent of S&P 500 s

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

During times of market volatility, many investors look to see which stocks Warren Buffett is buying. Spoiler alert, you won't find him chasing the hottest AI stocks.

DaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock.

Eva Ados, Eshares COO, joins ‘Power Lunch' to discuss three stocks: Tyson Foods, Campbell Soup and DaVita.

DaVita Inc ( DVA , Financial), a leading player in the Healthcare Providers & Services industry, is currently trading at $115.08 with a market capitalization of $10.51 billion. The stock has seen a ga

The shares of dialysis machine maker DaVita Inc (NYSE:DVA) are 6.6% higher to trade at $115.36 this morning, and earlier hit an 18-month high of $116.52.

DaVita Inc ( DVA , Financial), a leading player in the Healthcare Providers & Services industry, is currently trading at $108.76 with a market capitalization of $9.86 billion. The stock has seen a gai

DaVita's (DVA) robust dialysis patient service drives its second-quarter performance.

DaVita Inc. (NYSE:DVA ) Q2 2023 Earnings Conference Call August 3, 2023 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Office

DaVita HealthCare (DVA) came out with quarterly earnings of $2.08 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $2.30 per share a year ago.

DaVita Inc. DVA, -0.40% shares rose in the extended session Thursday after the dialysis center company topped Wall Street estimates, and hiked its forecast for the year. DaVita shares rose as much as